$WPC

W. P. Carey Inc. (WPC): Results of Operations and Financial Condition

W. P. Carey Inc. (WPC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 wpc2026q2supplementalexh992.htm EX-99.2 Document Exhibit 99.2 W. P. Carey Inc. Supplemental Information Second Quarter 2026 Terms and Definitions As used in this supplemental package, the terms “W. P. Carey,” “WPC,” “we,” “us” and “our” include W. P. Carey Inc., its con

Original reporting
Published Jul 28, 2026, 8:08 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 8:13 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$WPC
Neutral
medium confidence
Mentioned
$WPC
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$WPCNeutralMed
01

Why it matters

Key disclosed metrics include Q2 revenues of $461.1M, net income attributable to WPC of $185.4M, AFFO attributable of $305.4M, and an annualized dividend of $3.76 with a 5.3% yield based on a $71.50 quarter-end share price. Leverage is shown as net debt to adjusted EBITDA (annualized) of 5.5x and net debt to enterprise value of 35.1%.

02

Market read

Provides fresh quarterly operating and leverage datapoints that can affect valuation multiples and dividend sustainability perceptions for income REIT investors.

03

What to watch

Traders may focus on tenant concentration, same-store contractual growth, and debt maturity/interest-rate sensitivity, but those details are only partially visible in the provided excerpt.

Relevance 7/10Novelty 6/10Timing: after-hours filing of Q2 2026 results on SEC EDGAR

Background

The document is W. P. Carey’s SEC Form 8-K Item 2.02 with supplemental information for the quarter ended June 30, 2026.

Company-level read

Ticker impact

$WPCNeutralMedium confidence
Context

W. P. Carey filed an 8-K with Q2 2026 operating results, including revenues, net income, AFFO, and dividend metrics.

Expected impact

Likely modest, with direction dependent on how investors interpret AFFO and leverage versus expectations.

Evidence & confidence

This is a primary-source quarterly results supplement (Item 2.02) with specific figures for AFFO, NOI, payout, and net debt/EBITDA, but the excerpt does not include guidance or a clear surprise versus prior quarters.

Market effects

Adds another data point on net-leased REIT fundamentals, including occupancy, lease term, and leverage ratios that can influence sector risk premia.

No explicit regional macro or property-market shock is disclosed in the excerpt.

Limited, as the filing is company-specific and does not cite cross-border regulatory or capital-market disruptions.

Counterpoint

If the market had already priced in Q2 performance, the incremental impact may be limited because the excerpt lacks any explicit guidance change or standout surprise item.

Key entities

  • W. P. Carey Inc.

    Net-leased REIT reporting Q2 2026 results and balance-sheet metrics via SEC 8-K Item 2.02 supplemental package.

Related articles

$MAAMed

Mid-America Apartment Communities Vs. W.P. Carey: Why One REIT Dividend Claimed 86% Of Core AFFO - W.P.

Mid-America Apartment Communities (MAA) reported Q2 Core AFFO of $1.77 per share, down from $1.85, and kept its quarterly dividend at $1.530. It narrowed full-year Core AFFO guidance to $7.38–$7.62 and said new-lease pricing fell 5.3%. W. P. Carey (WPC) reported Q2 AFFO of $1.34, raised its dividend to $0.940, and lifted/narrowed full-year AFFO guidance to $5.19–$5.27.

Med

Carey Gillam on the Supreme Court’s Decision in the Roundup Case

The US Supreme Court, in a 7-2 ruling in Monsanto v. Durnell, sided with Monsanto, now Bayer, holding that failure-to-warn claims are preempted when the EPA did not require a cancer warning for the pesticide. The decision is expected to limit Roundup-related cancer lawsuits. The article cites Bayer stock up 17% and says Bayer has paid over $11B and is offering $7.25B for class action settlement.

$ADSKMedAI 8/10

Autodesk earnings analysis: questions answered and next catalysts

Autodesk (ADSK) reported Q2 FY2027 earnings beating EPS ($3.30 vs. $3.12) and revenue ($2.05B vs. $2.01B) estimates, but shares fell 4.5% due to slightly lowered full-year EPS guidance. Revenue grew 18% YoY, margins expanded, and free cash flow guidance was raised. The MaintainX acquisition added customers but introduced near-term costs. Analysts remain bullish with a mean price target of $314.57.

$WDAYMedAI 8/10

Workday earnings analysis: questions answered and next catalysts

Workday (WDAY) reported Q2 FY2027 earnings beating revenue ($2.65B) and EPS ($2.75) estimates, but Q3 cRPO guidance (11-12%) missed expectations. AI products reached $600M ARR, up 200% YoY, while margins expanded to 31.1%. The company completed a $5B share buyback and authorized a new $4B program. Management did not address acquisition rumors. Next catalysts include Q3 earnings, potential Silver Lake deal, and AI monetization progress.

$CRMHighAI 8/10

Salesforce Has a $25 Billion Question Investors Aren’t Asking

Salesforce (CRM) reported Q2 revenue of $11.3B, up 11% YoY, with adjusted EPS rising 103% to $5.90. Management raised FY27 guidance to $46.1B-$46.4B, with $200M from acquisitions. The company announced a $25B share buyback, raising questions about capital allocation. CRM stock is down 2% YTD, with an average target price of $270.98.

$RBRKHighAI 8/10

Rubrik earnings analysis: questions answered and next catalysts

Rubrik (RBRK) reported Q2 FY2027 earnings with EPS of $0.20 (vs. $0.04 expected) and revenue of $427.3M (vs. $396.3M forecast), but shares fell 10.4% due to slower-than-expected cloud ARR growth. Subscription ARR grew 33% YoY, while cloud net new ARR grew 20%. Management highlighted Identity Resilience as a growth driver and confirmed no ARR contribution from the Strata acquisition. Free cash flow rose to $65.7M, and profitability targets were reaffirmed. Analysts remain bullish, with a mean pri